• 慢性心力衰竭的循证诊疗与管理
  • 慢性心力衰竭的循证诊疗与管理
21年品牌 40万+商家 超1.5亿件商品

慢性心力衰竭的循证诊疗与管理

新华书店全新正版,极速发货,假一罚十,可开电子发票,请放心购买。

249.15 6.3折 398 全新

库存10件

天津西青
认证卖家担保交易快速发货售后保障

作者徐俊波 编

出版社科学技术文献出版社

ISBN9787523516478

出版时间2024-09

装帧精装

开本16开

定价398元

货号1203422285

上书时间2024-11-06

果然是好书店

三年老店
已实名 已认证 进店 收藏店铺

   商品详情   

品相描述:全新
商品描述
作者简介
主编徐俊波主任医师,系四川省“天府名医”、四川省学术和技术带头人、四川省卫生健康领军人才、四川省卫健委学术技术带头人、成都市卫健委学术技术带头人、享受成都市人民政府特殊津、中国医院协会2016年优秀医院院长、“国家卫健委医疗管理服务指导专家库”成员、中国医院协会国际医疗服务与管理专业委员会常务委员,中国高血压联盟理事,中国高血压及相关疾病中青年专家论坛CHIEF成员、中国心脏康复联盟四川分盟主任委员、四川省医师协会副会长、四川省医师协会心血管专业委员会主任委员、、四川省医学会心血管专业委员会副主任委员、四川省中西医结合心血管专业委员会主任委员,成都市医学会心血管专业委员会副主任委员,《心血管病学进展》主编。主持/主研省市各级课题、横向课题、国际多中心研究10多项,获省、市科技进步奖4项,授权国家发明专利6项,实用新型专利6项。发表学术论文100余篇,SCI收录论文10多篇,中文核心期刊论文逾40篇,。主编/参编学术专著4部,已培养硕士研究生12名。

目录
第一章 慢性心力衰竭的流行病学 ······················································································· 1

第二章 慢性心力衰竭的病理生理机制 ················································································ 10

第三章 慢性心力衰竭的诊断和评估 ··················································································· 17

第一节 慢性心力衰竭诊断概述 ··················································································· 17

第二节 超声心动图诊断 ···························································································· 21

第三节 放射学诊断 ·································································································· 31

第四节 慢性心力衰竭的评估 ······················································································ 56

第四章 慢性心力衰竭的药物治疗 ······················································································ 86

第一节 血管紧张素转换酶(受体、受体脑啡肽酶)抑制剂 ··············································· 86

第二节 β受体阻滞剂 ······························································································ 105

第三节 钠.-葡萄糖耦联转运体 2抑制剂 ······································································ 121

第四节 盐皮质激素受体拮抗剂 ················································································· 130

第五节 正性肌力药物 ····························································································· 146

第六节 利尿剂······································································································· 158

第七节 药物方案的调整及优化 ················································································· 162

第五章 慢性心力衰竭的非药物治疗 ················································································· 168

第一节 连续性肾脏替代治疗 ···················································································· 168

第二节 起搏治疗 ··································································································· 179

第三节 心脏收缩力调节器 ······················································································· 197

第四节 主动脉内球囊反搏 ······················································································· 205

第五节 体外膜肺氧合 ······························································································211

第六节 微轴向心室辅助装置(以 Impella为例) ··························································· 219

第七节 颈动脉窦刺激及交感节神经消融 ····································································· 230

第八节 二尖瓣外科成形术及介入技术 ········································································ 238

第九节 左心室减容术 ····························································································· 249 

第十节 心室辅助装置 ····························································································· 257

第十一节 心脏移植 ································································································ 265

第六章 慢性心力衰竭合并其他疾病 ················································································· 276

第一节 高血压······································································································· 276

第二节 冠心病······································································································· 284

第三节 心房颤动 ··································································································· 293

第四节 糖尿病······································································································· 316

第五节 肥厚型心肌病 ····························································································· 330

第六节 扩张型心肌病 ····························································································· 340

第七节 心脏淀粉样变性 ·························································································· 360

第八节 炎症性心肌病 ····························································································· 366

第九节 心肾综合征 ································································································ 376

第十节 呼吸系统疾病 ····························································································· 387

第十一节 甲状腺疾病 ····························································································· 404

第十二节 肺动脉高压 ····························································································· 413

第十三节 瓣膜性心脏病 ·························································································· 431

第十四节 抗肿瘤治疗相关心力衰竭 ··········································································· 443

第十五节 结缔组织疾病 ·························································································· 455

第七章 慢性心力衰竭的康复治疗 ···················································································· 463

第一节 体力活动的益处和风险 ················································································· 463

第二节 运动前筛查及评估 ······················································································· 464

第三节 运动测试和结果分析 ···················································································· 469

第四节 运动处方 ··································································································· 472

第五节 促进主动运动的策略 ···················································································· 475

第八章 慢性心力衰竭的全程管理 ···················································································· 483

第九章 干细胞治疗在心力衰竭中的应用 ··········································································· 491

附录 心力衰竭相关的重要临床研究 ················································································· 498 

内容摘要
心血管疾病已经成为我国城乡居民的首要死亡原因,给人民和社会的带来的经济负担日益加重。其中,心力衰竭作为诸多心血管疾病的终末阶段,是二十一世纪最重要的心血管病之一,其死亡率和癌症相当,是严重影响人民健康的重要公共卫生问题。近年来,心血管病学领域取得了巨大进展。基础医学及相关学科的发展,进一步丰富了对心血管疾病发病和病理生理机制的认识。心力衰竭领域的进展一日千里,有鉴于此,我们亟需一本能反映此领域最新循证医学进展的专著,以供广大心血管专科医师参考。本书围绕慢性心力衰竭这个主题,重点关注慢性心衰的临床诊疗及管理,介绍慢性心力衰竭的流行病学、病理生理机制最新药物和非药物治疗进展、康复及管理理念,并结合心衰不同病因及合并疾病情况进行介绍,尽可能的反映出近年来慢性心衰领域的前沿诊疗措施和技术。

主编推荐
心血管疾病已经成为我国城乡居民的首要死亡原因,给人民和社会的带来的经济负担日益加重。其中,心力衰竭作为诸多心血管疾病的终末阶段,是二十一世纪最重要的心血管病之一,其死亡率和癌症相当,是严重影响人民健康的重要公共卫生问题。近年来,心血管病学领域取得了巨大进展。基础医学及相关学科的发展,进一步丰富了对心血管疾病发病和病理生理机制的认识。心力衰竭领域的进展一日千里,有鉴于此,我们亟需一本能反映此领域最新循证医学进展的专著,以供广大心血管专科医师参考。本书围绕慢性心力衰竭这个主题,重点关注慢性心衰的临床诊疗及管理,介绍慢性心力衰竭的流行病学、病理生理机制最新药物和非药物治疗进展、康复及管理理念,并结合心衰不同病因及合并疾病情况进行介绍,尽可能的反映出近年来慢性心衰领域的前沿诊疗措施和技术。

—  没有更多了  —

以下为对购买帮助不大的评价

此功能需要访问孔网APP才能使用
暂时不用
打开孔网APP